How many institutions own EVAX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own EVAX shares is 19, representing 9.4% of the company's common stock.

Who are the major shareholders selling Evaxion Biotech A/S stock?

STONEPINE CAPITAL MANAGEMENT, LLC, in the last quarter, reduced its stake in EVAX by -1.44% restricting it's holding to 19.71 thousand shares of worth nearly $73.33K. also lessened -9.12% of the EVAX shares from its portfolio, reducing its holding to 13.81 thousand shares of worth $51.37K. ROYAL BANK OF CANADA also shunned EVAX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying EVAX stock?

As per its latest 13F filing, RATHBONES GROUP PLC increased its stake in EVAX by 100% in the last quarter. The institutional holder raised its holding to 45.72 thousand shares having worth more than $170.09K. ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC also added 100% more shares of EVAX to its portfolio, raising its holding to 30 thousand shares of worth $111.60K. RHUMBLINE ADVISERS also increased its EVAX shares holding by 2.7% which brought its holding to 21.66 thousand shares worth $80.56K.

EVAX's major insiders: who are they?

The insider with the most stakes in EVAX is N/A , N/A at the company. Additionally, EVAX stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell EVAX stock?

Company executives, directors, and other insiders own 17.47% percent of Evaxion Biotech A/S's stock. Within the last six months, there have been 0 transaction(s) in which EVAX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased EVAX stock?

There have been 0 transaction(s) during the past 6-months in which Evaxion Biotech A/S insiders have bought stock, totalling 0 shares

How much of EVAX does insiders own?

Around 0 Evaxion Biotech A/S shares are held by insiders, which represents about 17.47% of EVAX stock.

Who is the insider with the largest stake?

EVAX N/A, N/A holds the largest portfolio of the company's shares. EVAX shares owned by N/A total nearly -.

Which institution holds the most shares in EVAX?

RATHBONES GROUP PLC is the largest institutional owner in EVAX which holds 45.72 thousand shares worth $170.09K or 0.55% of the total EVAX shares outstanding followed by ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC with ownership of 30 thousand shares representing 0.36% of the EVAX ownership. RHUMBLINE ADVISERS is the third largest stakeholder with 21.66 thousand shares or 0.26% of the ownership worth more than $80.56K.

Is Evaxion Biotech A/S stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the EVAX is concerned, it is a stock which is not optionable.

Is there a short position on EVAX's shares?

Number of EVAX shares short is 117.81K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding EVAX shares are there?

As of today, 6.32M shares of EVAX are outstanding.

Is there many float in EVAX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, EVAX has 177.29M shares in float.

EVAX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for EVAX is 1.03.

Stock Ideas

EVAX Stock Ownership Breakdown

NASDAQ : EVAX

Evaxion Biotech A/S

$3.09

0.0679+2.25%

Open: 9:48 AM

69.35

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.87

Short Percent Of Float2.47

Shares Outstanding6.32M

Shares Float177.29M

Shares Short117.81K

Short Ratio1.03

2.47%

Short % of Float

1.87%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

17.47% Percentage of Shares held by All Insiders

9.4% Percentage of Shares held by All Institutions

11.39% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 9.4% of EVAX shares are held by financial institutions. RATHBONES GROUP PLC is the top corporate investor, holding 45.72K shares valued at $170.09K. A 0.55% stake in Evaxion Biotech A/S is owned by the company. ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC owns 30K shares valued at $111.60K, which translates its holding of 0.36% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	RATHBONES GROUP PLC	0.55%	45.72K	170.09K	45.72K	+100.00%
Mar 31, 2026	ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC	0.36%	30K	111.6K	30K	+100.00%
Mar 31, 2026	RHUMBLINE ADVISERS	0.26%	21.66K	80.56K	569	+2.70%
Mar 31, 2026	STONEPINE CAPITAL MANAGEMENT, LLC	0.24%	19.71K	73.33K	-287	-1.44%
Mar 31, 2026	CITADEL ADVISORS LLC	0.21%	17.77K	66.12K	17.77K	+100.00%
Mar 31, 2026		0.17%	13.81K	51.37K	-1.39K	-9.12%
Mar 31, 2026	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0.1%	8K	29.76K	0	0
Mar 31, 2026	WESBANCO BANK INC	0.12%	10K	37.2K	0	0
Mar 31, 2026	RENAISSANCE TECHNOLOGIES LLC	0.47%	39.23K	145.92K	39.23K	+100.00%
Mar 31, 2026	SBI SECURITIES CO., LTD.	0%	62	231	0	0
Mar 31, 2026	ROYAL BANK OF CANADA	0%	0	-	-3.9K	-100.00%
Mar 31, 2026	POINT72 ASSET MANAGEMENT, L.P.	0%	0	-	-33.1K	-100.00%
Mar 31, 2026	UBS GROUP AG	0%	0	-	-3.22K	-100.00%
Mar 31, 2026	IKARIAN CAPITAL, LLC	0.9%	74.7K	277.88K	0	0
Mar 31, 2026	BOOTHBAY FUND MANAGEMENT, LLC	0.22%	18.43K	68.55K	0	0
Mar 31, 2026	XTX TOPCO LTD	0.26%	22.05K	82.04K	22.05K	+100.00%
Mar 31, 2026	GAMMA INVESTING LLC	0.06%	5.2K	19.34K	1.36K	+35.33%
Mar 31, 2026	EVERSOURCE WEALTH ADVISORS, LLC	0.03%	2.27K	8.43K	-441	-16.29%
Dec 31, 2023	LM ADVISORS LLC	0.11%	337.34K	231.31K	337.34K	+100.00%
Dec 31, 2023	RHUMBLINE ADVISERS	0%	2.91K	2K	800	+37.93%
Dec 31, 2023	TWO SIGMA SECURITIES, LLC	0%	0	-	-15.19K	-100.00%
Dec 31, 2023	BEACON CAPITAL MANAGEMENT, LLC	0.02%	48.63K	40.51K	41.75K	+606.77%
Dec 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0%	14K	10K	14K	+100.00%
Dec 31, 2023	JPMORGAN CHASE & CO	0%	9K	6.17K	-286	-3.08%
Dec 31, 2023	GROUP ONE TRADING, L.P.	0%	386	265	0	0
Dec 31, 2023	MORGAN STANLEY	0%	0	-	-3.45K	-100.00%
Dec 31, 2023	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-11K	-100.00%
Dec 31, 2023	AE WEALTH MANAGEMENT LLC	0%	0	-	-48.63K	-100.00%
Dec 31, 2023	MOLONEY SECURITIES ASSET MANAGEMENT, LLC	0%	0	-	-11K	-100.00%
Dec 31, 2023		12.2%	337.34K	231.31K	337.34K	+100.00%
Dec 31, 2023	CITADEL ADVISORS LLC	0%	1.3K	891	1.3K	+100.00%
Dec 31, 2023	UBS GROUP AG	0%	277	190	-3.73K	-93.08%

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.